Hematology NewsOral triplet deemed effective in relapsed/refractory myelomaMarch 13, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsMyeloma risk score has treatment-planning potentialMarch 12, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsMyeloma therapies raise cardiovascular risksMarch 1, 2019Multiple MyelomaThrombosisLymphoma & Plasma Cell DisordersPreventive Care
Hematology NewsSelinexor hits FDA stumbling blockFebruary 26, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsMRD negativity linked to survival in MM after auto-HCTFebruary 24, 2019TransplantationMultiple MyelomaCellular TherapyLymphoma & Plasma Cell Disorders
Hematology NewsSimilar results for once- or twice-weekly carfilzomib in MMFebruary 23, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersRare Diseases
Hematology NewsFDA approves daratumumab split-dosing regimen in MMFebruary 13, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsTrial supports less aggressive myeloma treatmentFebruary 8, 2019Multiple MyelomaLymphoma & Plasma Cell DisordersRare Diseases
Oncology PracticeAML, myeloma risk higher for breast cancer survivorsJanuary 22, 2019Breast CancerLeukemia, Myelodysplasia, TransplantationAMLMultiple Myeloma
Hematology NewsWith RRMM and renal impairment, carfilzomib improves survivalJanuary 22, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsNext-generation anti-BCMA CAR T shows promise for RRMMJanuary 16, 2019Multiple Myeloma
Hematology TimesGroup proposes new grading systems for CRS, neurotoxicityJanuary 3, 2019Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantationALLNon-Hodgkin LymphomaAggressive Lymphomas
Hematology TimesEC approves split dosing regimen for daratumumabJanuary 3, 2019Multiple MyelomaPharmacy
Hematology NewsFrailty-adjusted treatment strategy emerges in myelomaDecember 21, 2018Multiple MyelomaLymphoma & Plasma Cell Disorders
